Centene Corporation (CNC) — Fair Value Analysis

Base-case fair value (P50): $70.79 · Current price: $58.27 · Verdict: Undervalued

The Verdict on CNC

Centene Corporation (CNC) appears significantly undervalued based on our latest Monte Carlo simulations. With a current market price of $59.24, our analysis indicates a median fair value (P50) of $72.19. This represents a substantial +21.9% upside potential from its present trading level, suggesting that the market may be overlooking CNC's intrinsic value. Our verdict points to a clear undervaluation for the Healthcare sector stock.

How CNC stacks up against Healthcare

While Centene Corporation (CNC) demonstrates an average quality tier, reflecting its operational and financial health relative to the broader Healthcare sector, this does not detract from its current undervaluation. Despite an average standing, Monte Carlo simulations consistently yield a fair value of $72.19, significantly above the $59.24 current price. This suggests that even with its average quality profile, the market is not fully appreciating the company’s forward potential, offering a +21.9% gap for investors.

What this means for investors

For investors, the +21.9% upside from the current $59.24 to the P50 fair value of $72.19 presents a compelling opportunity in Centene Corporation (CNC). The median fair value is derived from thousands of forward-looking scenarios generated by our Monte Carlo simulations, providing a robust, probabilistic estimate. While this P50 represents the most likely outcome, our comprehensive FairCurve analysis also models potential downside scenarios and more optimistic bull cases, all without revealing specific values to non-subscribers. To see the full bear and bull distribution and track CNC's fair value as new fundamentals are released, sign up for FairCurve today.